Doctor profile · Federal record
Dr. Gregory Borstad
Rheumatology Physician (CMS: Hospitalist) · Hospitalist Physician · Wilmington, NC
- NPI 1528057056
- Accepts Medicare
- MIPS 92.1 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1710 S 17Th St
Wilmington, NC 284016442
(910) 762-1182 - Additional location
-
3333 Silas Creek Pkwy
Winston Salem, NC 271033013
(336) 718-8383
fax (336) 718-9622
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- February 8, 2024
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- North Carolina #2014-00896
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1528057056. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
74,141
Distinct HCPCS
10
Medicare allowed
$2,009,936
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 25,725 | 57 | $42 | |
J3262 |
Injection, tocilizumab, 1 mg | 16,320 | 14 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 14,377 | 25 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,110 | 39 | $33 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,390 | 23 | $40 | |
J0897 |
Injection, denosumab, 1 mg | 1,920 | 20 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 759 | 232 | $122 | |
82565 |
Blood creatinine level | 730 | 232 | $5 | |
80076 |
Liver function blood test panel | 689 | 213 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 684 | 205 | $8 |
In context: peer comparison
Among 5 peers in Wilmington Rheumatology Physician, average services per provider: 1,945. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$122
Transactions
6
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $25.85 | |
| Sandoz INC. | 1 | $23.48 | |
| Fresenius Kabi USA, LLC | 1 | $22.99 | |
| Lilly USA, LLC | 1 | $18.15 | |
| Janssen Biotech, INC. | 1 | $17.26 | |
| Amgen INC. | 1 | $14.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
818
Patients
164
Total drug cost
$194,776
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tramadol Hcl | Generic | 163 | 28 | $1,958 |
| Prednisone | Generic | 144 | 45 | $1,149 |
| Methotrexate (Methotrexate Sodium) | Brand | 120 | 38 | $3,386 |
| Allopurinol | Generic | 73 | 20 | $1,183 |
| Hydroxychloroquine Sulfate | Generic | 58 | 20 | $2,785 |
| Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50) | Brand | 48 | 0 | $170,959 |
| Celecoxib | Generic | 30 | 0 | $5,140 |
| Sulfasalazine | Generic | 29 | 0 | $1,070 |
| Alendronate Sodium | Generic | 26 | 13 | $260 |
| Colchicine | Generic | 26 | 0 | $3,636 |
Frequently asked questions
What is Dr. Gregory Borstad's medical specialty?
Dr. Gregory Borstad practices Rheumatology Physician in Wilmington, NC.
Where does Dr. Gregory Borstad practice?
Dr. Gregory Borstad practices at 1710 S 17Th St, Wilmington, NC 284016442. Office phone: 9107621182.
What is Dr. Gregory Borstad's NPI?
Dr. Gregory Borstad's National Provider Identifier (NPI) is 1528057056, issued by NPPES.
Does Dr. Gregory Borstad accept Medicare assignment?
Yes. Dr. Gregory Borstad accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gregory Borstad commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.